{"author": "Merz, M ", "adress": "Univ Hosp Leipzig, Dept Hematol, Cell Therapy & Hemostaseol, D-04103 Leipzig, Germany", "emails": ["Maximilian.Merz@medizin.uni-leipzig.de", "hartmut.goldschmidt@med.uni-heidelberg.de", "phari@mcw.edu", "aghame@upmc.edu", "JDIELS@its.jnj.com", "FGhilott@its.jnj.com", "NPeruali@its.jnj.com", "JCabriet@ITS.JNJ.com", "BHaeflig@its.jnj.com", "HSliwka@its.jnj.com", "schecte@ITS.JNJ.com", "CJacks66@its.jnj.com", "YOLYSLA@its.jnj.com", "Muhammad.Akram@legendbiotech.com", "tonia.nesheiwat@legendbiotech.com", "kellermann@OncologyInformationService.com", "Sundar.Jagannath@mountsinai.org"], "title": "Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry"}